HCP 1302

Drug Profile

HCP 1302

Alternative Names: HCP1302

Latest Information Update: 16 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class Erectile dysfunction therapies; Small interfering RNA
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Erectile dysfunction; Hypertension

Most Recent Events

  • 31 Dec 2015 Preregistration for Erectile dysfunction in South Korea (unspecified route)
  • 31 Dec 2015 Preregistration for Hypertension in South Korea (unspecified route)
  • 01 Sep 2015 Phase-III clinical trials in Erectile dysfunction in South Korea (unspecified route) (NCT02587988)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top